11/8/19 12:26 | 9/30/19 | MSLP | Health | Drug | Pharmaceutical Preparations | White Winston Select Asset Fund Series Fund Mp-18, LLC | MA | T | | P.a | 0 | 0.00 | 0 | 627 | 21 | 3,648 | D | | | | | | | | | | | | | | |
11/8/19 12:18 | 9/27/19 | MSLP | Health | Drug | Pharmaceutical Preparations | White Winston Select Asset Fund Series Fund Mp-18, LLC | MA | T | | P.a | 0 | 0.00 | 0 | 94 | 3 | 3,022 | D | | | | | | | | | | | | | | |
10/2/19 21:36 | 9/30/19 | MSLP | Health | Drug | Pharmaceutical Preparations | White Winston Select Asset Fund Series Fund Mp-18, LLC | MA | T | | P | 0 | 0.00 | 0 | 627 | 21 | 3,658 | D | | | | | | | | | | | | | | |
10/1/19 20:18 | 9/27/19 | MSLP | Health | Drug | Pharmaceutical Preparations | White Winston Select Asset Fund Series Fund Mp-18, LLC | MA | T | | P | 0 | 0.00 | 0 | 104 | 4 | 3,031 | D | | | | | | | | | | | | | | |
10/1/19 16:14 | 9/27/19 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 3 | 0.5300 | 0 | 5 | 0 | 1,936 | M | | | | | | | | | | | | | | |
8/21/19 16:15 | 8/19/19 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P.m | 6 | 0.4000 | 0 | 15 | 1 | 1,931 | I | | | | | | | | | | | | | | |
8/16/19 16:23 | 8/14/19 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P.m | 4 | 0.4038 | 0 | 10 | 1 | 1,916 | I | | | | | | | | | | | | | | |
8/7/19 16:15 | 8/5/19 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 3 | 0.5000 | 0 | 5 | 0 | 1,906 | M | | | | | | | | | | | | | | |
4/10/19 16:17 | 4/8/19 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 8 | 0.6000 | 0 | 13 | 1 | 1,901 | M | | | | | | | | | | | | | | |
3/21/19 16:16 | 3/19/19 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 3 | 0.6300 | 0 | 5 | 0 | 1,889 | M | | | | | | | | | | | | | | |
3/8/19 16:15 | 3/6/19 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 8 | 0.6300 | 0 | 12 | 1 | 1,884 | M | | | | | | | | | | | | | | |
2/8/19 16:15 | 2/6/19 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P.m | 40 | 0.4000 | 0 | 100 | 6 | 1,871 | M | | | | | | | | | | | | | | |
1/3/19 16:31 | 12/31/18 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 16 | 0.5713 | 0 | 28 | 2 | 1,771 | I | | | | | | | | | | | | | | |
12/31/18 16:16 | 12/27/18 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 1 | 0.5655 | 0 | 2 | 0 | 1,743 | I | | | | | | | | | | | | | | |
12/13/18 16:24 | 12/11/18 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P.m | 54 | 0.8967 | 0 | 60 | 3 | 2,424 | I | | | | | | | | | | | | | | |
12/4/18 16:32 | 11/30/18 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 6 | 0.8957 | 0 | 7 | 0 | 1,681 | I | | | | | | | | | | | | | | |
11/28/18 16:29 | 11/26/18 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P.m | 3 | 0.9000 | 0 | 3 | 0 | 2,357 | M | | | | | | | | | | | | | | |
10/18/18 16:15 | 10/16/18 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 15 | 1.00 | 0 | 15 | 1 | 1,671 | M | | | | | | | | | | | | | | |
8/23/18 16:18 | 8/21/18 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 13 | 1.00 | 0 | 13 | 1 | 1,656 | I | | | | | | | | | | | | | | |
7/12/18 16:19 | 7/6/18 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P.m | 93 | 0.9812 | 0 | 94 | 6 | 1,643 | M | | | | | | | | | | | | | | |
8/22/17 17:02 | 8/18/17 | MSLP | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | | P | 7 | 1.41 | 0 | 5 | 0 | 1,636 | M | | | | | | | | | | | | | | |
5/15/17 12:35 | 5/11/17 | MSLP | Health | Drug | Pharmaceutical Preparations | Amerop Holdings, Inc. | CO | T | | P | 150 | 2.00 | 0 | 75 | 4 | 2,212 | D | | | | | | | | | | | | | | |
4/11/17 17:46 | 4/10/17 | MSLP | Health | Drug | Pharmaceutical Preparations | Amerop Holdings, Inc. | CO | T | | P | 42 | 2.16 | 0 | 19 | 1 | 2,137 | D | | | | | | | | | | | | | | |
4/6/17 14:51 | 4/4/17 | MSLP | Health | Drug | Pharmaceutical Preparations | Amerop Holdings, Inc. | CO | T | | P.m | 187 | 2.14 | 0 | 88 | 4 | 2,117 | D | | | | | | | | | | | | | | |
11/25/14 16:16 | 11/21/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Lupo Andrew J | NJ | D | | P.m | 170 | 10.62 | 0 | 16 | 151 | 27 | M | | | | | | | | | | | | | | |
11/24/14 16:16 | 11/20/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Lupo Andrew J | NJ | D | | P | 22 | 10.10 | 0 | 2 | 150 | 4 | D | | | | | | | | | | | | | | |
11/20/14 16:51 | 11/20/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Greenwell James J | CO | O | COO | P | 10 | 9.90 | 0 | 1 | 1 | 162 | D | | | | | | | | | | | | | | |
11/20/14 16:02 | 11/20/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DO | CEO | P | 100 | 10.09 | 0 | 10 | 1 | 1,075 | D | | | | | | | | | | | | | | |
9/22/14 16:17 | 9/19/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Macosko Gregory | CO | D | | P | 13 | 13.21 | 0 | 1 | 100 | 2 | I | | | | | | | | | | | | | | |
9/5/14 16:15 | 9/5/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DO | CEO | P | 7 | 13.60 | 0 | 1 | 0 | 564 | D | | | | | | | | | | | | | | |
8/22/14 16:30 | 8/21/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DO | CEO | P.m | 65 | 12.15 | 0 | 5 | 1 | 564 | D | | | | | | | | | | | | | | |
8/15/14 08:30 | 8/14/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DO | CEO | P | 29 | 11.48 | 0 | 3 | 0 | 558 | D | | | | | | | | | | | | | | |
8/12/14 16:21 | 8/8/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Greenwell James J | CO | O | COO | P | 11 | 11.00 | 0 | 1 | 2 | 61 | D | | | | | | | | | | | | | | |
8/8/14 19:56 | 8/8/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DO | CEO | P | 169 | 11.27 | 0 | 15 | 3 | 556 | D | | | | | | | | | | | | | | |
5/14/14 16:01 | 5/12/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Doron Michael J | UT | D | | P | 10 | 10.14 | 0 | 1 | 2 | 53 | D | | | | | | | | | | | | | | |
5/8/14 16:03 | 5/8/14 | MSLP | Health | Drug | Pharmaceutical Preparations | Estalella Richard | CO | DO | P | P | 98 | 9.80 | 0 | 10 | 9 | 120 | D | | | | | | | | | | | | | | |
12/6/13 16:06 | 12/5/13 | MSLP | Health | Drug | Pharmaceutical Preparations | Estalella Richard | CA | DO | COO | P.m | 56 | 8.06 | 0 | 7 | 7 | 110 | D | | | | | | | | | | | | | | |
12/5/13 16:05 | 12/5/13 | MSLP | Health | Drug | Pharmaceutical Preparations | Davis Lewis Gary | CO | O | CFO | P | 16 | 7.97 | 0 | 2 | 1 | 223 | D | | | | | | | | | | | | | | |
12/5/13 16:05 | 12/5/13 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DOT | CEO | P | 93 | 8.05 | 0 | 12 | 2 | 541 | D | | | | | | | | | | | | | | |
12/5/13 16:03 | 12/3/13 | MSLP | Health | Drug | Pharmaceutical Preparations | Rollock Sydney R | PA | O | CMO | P.m | 68 | 8.11 | 0 | 8 | 135 | 15 | D | | | | | | | | | | | | | | |
12/2/13 12:29 | 11/27/13 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DOT | CEO | P | 75 | 8.48 | 0 | 9 | 2 | 529 | D | | | | | | | | | | | | | | |
11/27/13 06:03 | 11/26/13 | MSLP | Health | Drug | Pharmaceutical Preparations | Davis Lewis Gary | CO | O | CFO | P | 8 | 8.30 | 0 | 1 | 0 | 221 | D | | | | | | | | | | | | | | |
11/25/13 06:07 | 11/22/13 | MSLP | Health | Drug | Pharmaceutical Preparations | Rollock Sydney R | PA | O | CMO | P | 41 | 8.25 | 0 | 5 | 427 | 6 | D | | | | | | | | | | | | | | |
11/25/13 06:05 | 11/22/13 | MSLP | Health | Drug | Pharmaceutical Preparations | Estalella Richard | CA | DO | COO | P | 25 | 8.30 | 0 | 3 | 3 | 103 | D | | | | | | | | | | | | | | |
11/21/13 16:03 | 11/20/13 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DOT | CEO | P.m | 41 | 8.19 | 0 | 5 | 1 | 520 | D | | | | | | | | | | | | | | |
4/30/12 20:48 | 4/25/12 | MSLP | Health | Drug | Pharmaceutical Preparations | Deluca Jeremy R. | CO | DOT | Co-P,Chi | P | 10 | 0.0190 | 0 | 500 | 0 | 148,683 | D | | | | | | | | | | | | | | |
4/30/12 16:05 | 4/27/12 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DOT | CEO | P | 12 | 0.0186 | 0 | 672 | 0 | 168,799 | D | | | | | | | | | | | | | | |
4/27/12 10:42 | 4/24/12 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DOT | CEO | P.a | 25 | 0.0215 | 0 | 1,155 | 1 | 168,127 | D | | | | | | | | | | | | | | |
4/26/12 15:18 | 2/24/12 | MSLP | Health | Drug | Pharmaceutical Preparations | Pyatt Brad J | CO | DOT | CEO | P | 25 | 0.0215 | 0 | 1,155 | 1 | 168,127 | D | | | | | | | | | | | | | | |